Mechanism of Zuoguiwan in Inhibiting Osteoclast Activation Induced by Breast Cancer via Regulating p38 MAPK/ERK Signaling Pathway
|更新时间:2024-12-17
|
Mechanism of Zuoguiwan in Inhibiting Osteoclast Activation Induced by Breast Cancer via Regulating p38 MAPK/ERK Signaling Pathway
“The latest research found that Zuogui Pill can inhibit the activation of osteoclasts induced by breast cancer by activating p38 MAPK/ERK signaling pathway.”
Chinese Journal of Experimental Traditional Medical FormulaeVol. 31, Issue 1, Pages: 1-9(2025)
FU Jianjiang,MEI Yinlong,MA Junchao,et al.Mechanism of Zuoguiwan in Inhibiting Osteoclast Activation Induced by Breast Cancer via Regulating p38 MAPK/ERK Signaling Pathway[J].Chinese Journal of Experimental Traditional Medical Formulae,2025,31(01):1-9.
FU Jianjiang,MEI Yinlong,MA Junchao,et al.Mechanism of Zuoguiwan in Inhibiting Osteoclast Activation Induced by Breast Cancer via Regulating p38 MAPK/ERK Signaling Pathway[J].Chinese Journal of Experimental Traditional Medical Formulae,2025,31(01):1-9. DOI: 10.13422/j.cnki.syfjx.20241822.
Mechanism of Zuoguiwan in Inhibiting Osteoclast Activation Induced by Breast Cancer via Regulating p38 MAPK/ERK Signaling Pathway